Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ONCO-NK-TRANSITION-GM1 is a low-cost, effective cancer treatment with a high cure rate and no severe side effects.

ONCO-NK-TRANSITION-GM1 is a low-cost, effective cancer treatment with a high cure rate and no severe side effects.

Exosomes from plants and adipose tissue stem cells, combined with biomimetic polypeptides, show promise for safe and effective hair growth treatment.

Exosomes help nerve fibers grow by affecting specific cell signaling pathways.

Repurposing existing drugs can save time and money in finding new treatments.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Personalized treatments for hair loss are becoming more effective by using genetic information.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

Omics techniques are needed to understand the scalp microbiome's role in alopecia areata for new treatments.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Polydeoxyribonucleotides may help with healing and anti-aging, but more research is needed.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Single-cell sequencing can improve livestock health and productivity but faces challenges in precise cell analysis.

These new skin treatments are safer and more effective with minimal side effects.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.